The pathopharmacology of malignant hyperpyrexia

34Citations
Citations of this article
1Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Malignant hyperpyrexia is a dangerous complication of anaesthesia which occurs in individuals who have an underlying disease of muscle. Two predisposing myopathies have been defined. Studies in susceptible humans and in swine, with an apparently identical myopathy, have shown that when MH muscle is exposed to a precipitating anaesthetic agent there is a sudden rise in the concentration of calcium ions in the myoplasm. The precise nature of the inherited muscle membrane abnormality is not yet known, but pharmacological and biochemical studies indicate that is closely associated with the excitation-contraction coupling mechanism. © 1980.

Cite

CITATION STYLE

APA

Denborough, M. A. (1980). The pathopharmacology of malignant hyperpyrexia. Pharmacology and Therapeutics, 9(3), 357–365. https://doi.org/10.1016/0163-7258(80)90023-6

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free